Sarma P S, Shiu G, Neubauer R H, Baron S, Huebner R J
Proc Natl Acad Sci U S A. 1969 Apr;62(4):1046-51. doi: 10.1073/pnas.62.4.1046.
The availability of a potent inducer of interferon, the synthetic double-stranded RNA (poly I.poly C), prompted us to determine its possible prophylactic and/or therapeutic effect on virus-induced sarcomas of mice. When treatment was begun prior to virus inoculation and repeated on alternate days, the majority of NIH Swiss mice inoculated with Moloney or Friend pseudotypes of Moloney murine sarcoma virus failed to develop tumors. Other experiments suggested that repeated injections initiated even after the establishment of tumor nodules were also effective. Mice injected on the day of birth with poly I.poly C develop high titers of interferon. The evidence favors, but does not establish, the interpretation that the observed tumor inhibition is mediated through the induction of endogenous interferon. These experiments demonstrate that treatment with poly I.poly C is followed by a regression of established murine sarcoma infection in mice.
强效干扰素诱导剂——合成双链RNA(聚肌苷酸-聚胞苷酸,poly I.poly C)的出现,促使我们去确定其对小鼠病毒诱导肉瘤可能的预防和/或治疗作用。当在病毒接种前开始治疗并隔天重复时,接种莫洛尼鼠肉瘤病毒莫洛尼或弗瑞德假型的大多数NIH瑞士小鼠未发生肿瘤。其他实验表明,即使在肿瘤结节形成后开始重复注射也有效。出生当天注射poly I.poly C的小鼠会产生高滴度的干扰素。现有证据支持但未证实以下解释:观察到的肿瘤抑制是通过内源性干扰素的诱导介导的。这些实验表明,用poly I.poly C治疗后,已建立的小鼠肉瘤感染会在小鼠体内消退。